Dr. Sonpavde Discusses Current Clinical Trials in Penile Cancer

Guru Sonpavde, MD
Published: Thursday, Nov 30, 2017



Guru Sonpavde, MD, director of Bladder Cancer at the Dana-Farber Cancer Institute, discusses current clinical trials in penile cancer.

EGFR is overexpressed at the protein and gene expression level, and has gene amplification at the DNA level in penile cancer, making it a target, says Sonpavde.

In the HER family of inhibitors, there was a trial with dacomitinib that was recently published, showing a response rate in the first-line neoadjuvant setting of about 32%. And afatinib (Gilotrif) is being looked at in the post-platinum salvage setting.

Additionally, pembrolizumab (Keytruda) is being investigated in the post-platinum setting, and the combination of ipilimumab (Yervoy) plus nivolumab (Opdivo) is being investigated all rare cancers.
 


Guru Sonpavde, MD, director of Bladder Cancer at the Dana-Farber Cancer Institute, discusses current clinical trials in penile cancer.

EGFR is overexpressed at the protein and gene expression level, and has gene amplification at the DNA level in penile cancer, making it a target, says Sonpavde.

In the HER family of inhibitors, there was a trial with dacomitinib that was recently published, showing a response rate in the first-line neoadjuvant setting of about 32%. And afatinib (Gilotrif) is being looked at in the post-platinum salvage setting.

Additionally, pembrolizumab (Keytruda) is being investigated in the post-platinum setting, and the combination of ipilimumab (Yervoy) plus nivolumab (Opdivo) is being investigated all rare cancers.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Moving Forward From the Status Quo for the Treatment of Soft Tissue Sarcoma: Key Questions & New Answers to Optimize OutcomesAug 16, 20181.5
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Publication Bottom Border
Border Publication
x